Brief: Bavarian Nordic Outlook FY Revenue DKK 5.7-6.7 Bln
05/03/2025 07:03
March 5 (Reuters) - Bavarian Nordic A/S BAVA.CO: OUTLOOK FY REVENUE DKK 5,700-6,700 MILLION TRAVEL HEALTH BUSINESS GREW BY 22%, SIGNIFICANTLY ABOVE OUR EXPECTATIONS FOR THE YEAR WE WILL FURTHER GROW THE PORTFOLIO WITH THE ANTICIPATED LAUNCH OF THE CHIKUNGUNYA VACCINE IN THE FIRST HALF OF 2025 Source text: ID:nGNE1n72S4 Further company coverage: BAVA.CO (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bavarian Nordic A/S
See all newsBrief: Bavarian Nordic Gets Smallpox/Mpox Vaccine Supply Contract
Brief: Bavarian Nordic Secures Additional Government Contract For The Supply Of Smallpox/Mpox Vaccine
Brief: Bavarian Nordic Launches Final Tranche Of Buy-Back Program
Bavarian Nordic falls as high costs, lower vaccine sales hit Q1 results
Bavarian Nordic Q1 revenue falls as Public Preparedness unit sales decline